GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Labcorp Holdings Inc (NYSE:LH) » Definitions » Shiller PE Ratio

LH (Labcorp Holdings) Shiller PE Ratio : 17.91 (As of Apr. 25, 2025)


View and export this data going back to 1991. Start your Free Trial

What is Labcorp Holdings Shiller PE Ratio?

As of today (2025-04-25), Labcorp Holdings's current share price is $228.31. Labcorp Holdings's E10 for the quarter that ended in Dec. 2024 was $12.75. Labcorp Holdings's Shiller PE Ratio for today is 17.91.

The historical rank and industry rank for Labcorp Holdings's Shiller PE Ratio or its related term are showing as below:

LH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.47   Med: 20.12   Max: 26.91
Current: 17.91

During the past years, Labcorp Holdings's highest Shiller PE Ratio was 26.91. The lowest was 12.47. And the median was 20.12.

LH's Shiller PE Ratio is ranked better than
65.82% of 79 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.68 vs LH: 17.91

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Labcorp Holdings's adjusted earnings per share data for the three months ended in Dec. 2024 was $1.700. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $12.75 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Labcorp Holdings Shiller PE Ratio Historical Data

The historical data trend for Labcorp Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labcorp Holdings Shiller PE Ratio Chart

Labcorp Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.71 24.74 16.52 18.49 17.99

Labcorp Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.49 17.32 16.00 17.53 17.99

Competitive Comparison of Labcorp Holdings's Shiller PE Ratio

For the Diagnostics & Research subindustry, Labcorp Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's Shiller PE Ratio falls into.


;
;

Labcorp Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Labcorp Holdings's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=228.31/12.75
=17.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labcorp Holdings's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Labcorp Holdings's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.7/133.1571*133.1571
=1.700

Current CPI (Dec. 2024) = 133.1571.

Labcorp Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 0.040 99.621 0.053
201506 1.660 100.684 2.195
201509 1.500 100.392 1.990
201512 1.110 99.792 1.481
201603 1.580 100.470 2.094
201606 1.960 101.688 2.567
201609 1.710 101.861 2.235
201612 1.750 101.863 2.288
201703 1.750 102.862 2.265
201706 1.780 103.349 2.293
201709 1.650 104.136 2.110
201712 6.810 104.011 8.718
201803 1.670 105.290 2.112
201806 2.270 106.317 2.843
201809 3.100 106.507 3.876
201812 1.560 105.998 1.960
201903 1.860 107.251 2.309
201906 1.930 108.070 2.378
201909 2.250 108.329 2.766
201912 2.320 108.420 2.849
202003 -3.270 108.902 -3.998
202006 2.370 108.767 2.901
202009 7.170 109.815 8.694
202012 9.540 109.897 11.559
202103 7.820 111.754 9.318
202106 4.760 114.631 5.529
202109 6.050 115.734 6.961
202112 5.750 117.630 6.509
202203 5.230 121.301 5.741
202206 3.870 125.017 4.122
202209 3.900 125.227 4.147
202212 0.860 125.222 0.914
202303 2.390 127.348 2.499
202306 2.120 128.729 2.193
202309 2.110 129.860 2.164
202312 -1.970 129.419 -2.027
202403 2.690 131.776 2.718
202406 2.430 132.554 2.441
202409 2.000 133.029 2.002
202412 1.700 133.157 1.700

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Labcorp Holdings  (NYSE:LH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Labcorp Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Labcorp Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Labcorp Holdings Business Description

Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Executives
Amy B. Summy officer: EVP, Chief Marketing Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Mark S Schroeder officer: EVP, President-Diagnostics Lab 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Kerrii B Anderson director WENDY'S INTERNATIONAL, INC, 4288 WEST DUBLIN-GRANVILLE RD., DUBLIN OH 43017
Van Der Vaart Sandra D officer: SVP, Global General Counsel 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Adam H Schechter director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Dwight Gary Gilliland director 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Glenn A Eisenberg officer: Chief Financial Officer, EVP P O BOX 1017, CHARLOTTE NC 28201-1017
Lance Berberian officer: SVP, Chief Information Officer
Peter J Wilkinson officer: SVP, Chief Accounting Officer C/O PHARMACEUTICAL PRODUCT DEVELOPMENT, 929 NORTH FRONT STREET, WILMINGTON NC 28401
Paul Rothman director 6 MEADOW ROAD, BALTIMORE MD 21212
Paul R Kirchgraber officer: CEO, Covance Drug Development 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Megan D. Bailey officer: EVP, Chief Strategy Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Jonathan P. Divincenzo officer: EVP, Pres, Central Labs & Intl 940 WINTER STREET, PERKINELMER, INC. LEGAL DEPARTMENT, WALTHAM MA 02451
Anita Z Graham officer: EVP, CHRO C/O THE ADT CORPORATION, 1501 YAMATO ROAD, BOCA RATON FL 33431
Thomas Pike officer: Pres & CEO Clinical Business C/O ACCENTURE, 161 N. CLARK STREET, 23RD FLOOR, CHICAGO IL 60601